Advanced Biomed Inc.
ADVB
$0.42
$0.001.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -48.49% | -17.14% | 7.84% | -- | -- |
| Total Depreciation and Amortization | -29.79% | -13.96% | 56.82% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -100.00% | -- | -- |
| Change in Net Operating Assets | -1,113.17% | -1,234.91% | -212.96% | -- | -- |
| Cash from Operations | -316.79% | -173.95% | -222.20% | -- | -- |
| Capital Expenditure | 85.77% | 57.41% | 72.04% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 85.77% | 57.41% | 70.74% | -- | -- |
| Total Debt Issued | -35.19% | -34.53% | -2.40% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 116.44% | 100.00% | 1,096.75% | -- | -- |
| Cash from Financing | 207.76% | 217.89% | 601.35% | -- | -- |
| Foreign Exchange rate Adjustments | 272.08% | -31.60% | -61.62% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -84.11% | 2,169.23% | 1,778.09% | -- | -- |